pulmonary arterial hypertension
Conditions
Interventions
increase in the daily activity (MET * hour) for 12 weeks
control
Sponsors
Department of clinical pharmacology & therapeutics, Hamamatsu University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: the patients with pulmonary arterial hypertension who can walk without any help.
Exclusion criteria
Exclusion criteria: The patients who can not walk.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| peak oxygen consumption, 6 minutes walk distance, shuttle walking test, and QOL assessment | — |
Countries
Japan
Contacts
Public ContactHiroshi Irisawa
Hamamatsu University School of Medicine department of clinical pharmacology & therapeutics
Outcome results
None listed